📊 CGC Key Takeaways
Is Canopy Growth Corp (CGC) a Good Investment?
Insufficient financial data available for fundamental analysis—only 2 of 35+ expected metrics are accessible. Inability to review revenue, profitability, balance sheet strength, and cash flow represents a critical barrier to due diligence and suggests transparency or reporting issues.
Canopy Growth’s fundamentals are improving, with Q3 FY2026 net loss narrowing 49% year over year, free cash outflow improving, and leverage easing as debt falls against a much larger cash balance. However, the business is still structurally unprofitable, revenue is roughly flat, margins remain pressured, and liquidity improvement has depended heavily on external financing and share issuance rather than internally generated cash.
Canopy Growth Corp Key Strengths (CGC)
- Recent insider Form 4 filings (4 in last 90 days) indicate management activity and engagement
- Operates in regulated medicinal chemicals sector with established market presence
- Nasdaq-listed company with regulatory oversight structure in place
- Balance sheet liquidity improved materially, with cash and cash equivalents of C$371 million at December 31, 2025 and total liabilities down versus March 31, 2025.
- Operating performance is stabilizing, with stronger Canada medical and adult-use cannabis sales and a third straight quarter of adjusted EBITDA improvement.
- Debt burden has been reduced and refinancing actions extended maturities, lowering near-term balance sheet stress.
CGC Stock Risks: Canopy Growth Corp Investment Risks
- Complete absence of reported revenue, profitability, and net income metrics
- No balance sheet data available—cannot assess asset base, liabilities, or equity position
- Zero cash flow visibility; unable to evaluate liquidity, operating efficiency, or capital allocation
- Data freshness dated 2026-03-31 with severe gaps suggests incomplete reporting or data integrity issues
- The company remains loss-making, with Q3 FY2026 operating loss of C$26 million and net loss of C$63 million, so profitability is still not proven.
- Cash generation is weak: operations used cash and free cash flow remained negative, meaning the turnaround is not yet self-funding.
- Growth quality is mixed because revenue is flat overall and the capital structure has been heavily diluted, with common shares outstanding rising sharply.
Key Metrics to Watch
- Revenue growth and gross margin trends when data becomes available
- Operating cash flow generation and free cash flow sustainability
- Balance sheet ratios: current ratio, debt-to-equity, and cash position adequacy
- Sustainable positive adjusted EBITDA and free cash flow from operations without reliance on equity financing
- Net revenue growth and gross margin in Canada cannabis and international medical markets
Canopy Growth Corp (CGC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CGC Profit Margin, ROE & Profitability Analysis
CGC vs Materials Sector: How Canopy Growth Corp Compares
How Canopy Growth Corp compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Canopy Growth Corp Stock Overvalued? CGC Valuation Analysis 2026
Based on fundamental analysis, Canopy Growth Corp has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Canopy Growth Corp Balance Sheet: CGC Debt, Cash & Liquidity
CGC Revenue Growth, EPS Growth & YoY Performance
CGC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Canopy Growth Corp (CIK: 0001737927)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CGC
What is the AI rating for CGC?
Canopy Growth Corp (CGC) has a Combined AI Grade of C from Claude (C) and ChatGPT (C) with 52% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CGC's key strengths?
Claude: Recent insider Form 4 filings (4 in last 90 days) indicate management activity and engagement. Operates in regulated medicinal chemicals sector with established market presence. ChatGPT: Balance sheet liquidity improved materially, with cash and cash equivalents of C$371 million at December 31, 2025 and total liabilities down versus March 31, 2025.. Operating performance is stabilizing, with stronger Canada medical and adult-use cannabis sales and a third straight quarter of adjusted EBITDA improvement..
What are the risks of investing in CGC?
Claude: Complete absence of reported revenue, profitability, and net income metrics. No balance sheet data available—cannot assess asset base, liabilities, or equity position. ChatGPT: The company remains loss-making, with Q3 FY2026 operating loss of C$26 million and net loss of C$63 million, so profitability is still not proven.. Cash generation is weak: operations used cash and free cash flow remained negative, meaning the turnaround is not yet self-funding..
What is CGC's revenue and growth?
Canopy Growth Corp reported revenue of N/A.
Does CGC pay dividends?
Canopy Growth Corp does not currently pay dividends.
Where can I find CGC SEC filings?
Official SEC filings for Canopy Growth Corp (CIK: 0001737927) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CGC's EPS?
Canopy Growth Corp has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is CGC's fundamental grade?
Based on our AI fundamental analysis in June 2026, Canopy Growth Corp has a C grade with 52% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is CGC stock overvalued or undervalued?
Valuation metrics for CGC: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is CGC's AI grade for 2026?
Our dual AI analysis gives Canopy Growth Corp a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CGC's free cash flow?
Canopy Growth Corp's operating cash flow is N/A, with capital expenditures of N/A.
How does CGC compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio N/A (avg: 1.6).